Fabp5 是关键调节者,调解骨质母细胞和骨质母细胞的γ-CEHC分化
Cheng Cheng1, Rong Chen1, Minjuan Li2
1Department of Osteoporosis, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
维生素E代谢物γ-CEHC通过向脂肪酸结合蛋白5 (Fabp5) 来治疗骨质疏松症. 它可以减少炎症和氧化应激,改善骨代谢和恒温.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症与氧化应激和炎症有关.
- 维生素E代谢物γ-CEHC具有抗氧化和抗炎性质.
- 在骨代谢中γ-CEHC的分子点在很大程度上是未知的.
研究的目的:
- 为了识别g-CEHC的蛋白标.
- 阐明γ-CEHC在调节骨代谢中的作用.
- 为了研究γ-CEHC作为治疗骨质疏松症的治疗剂.
主要方法:
- 卵巢切除 (OVX) 的小鼠模型和体外试验.
- 异热热蛋白质形 (TPP) 用于识别蛋白质标.
- 细胞热转移测定 (CETSA) 和表面等离子体共振 (SPR) 用于结合确认.
主要成果:
- 在OVX小鼠中,γ-CEHC抑制骨质细胞分化并增强骨质细胞分化.
- 脂肪酸结合蛋白5 (Fabp5) 被确定为γ-CEHC.的核心标.
- γ-CEHC抑制M1巨细胞的激活,促进M2极化,并减少活性氧物种 (ROS).
结论:
- γ-CEHC作为Fabp5的选择性配体,为骨质疏松症提供了一种新的治疗方法.
- γ-CEHC通过调节巨细胞极化和减少氧化应激来改善骨代谢.
- 这项研究为在骨质疏松症治疗中准Fabp5提供了机制基础.
更多相关视频
08:07Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice
Published on: January 6, 2018
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
相关概念视频
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
08:07Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
11:52Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
10:52Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
11:11Isolation, Purification, and Differentiation of Osteoclast Precursors from Rat Bone Marrow
